Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Oort, I.M. van
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(6)
+
-
Availability
Open access
(1)
+
-
Metadata Only
(5)
+
-
Creation Date
2013
(2)
+
-
2016
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(5)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(5)
+
-
Topic
Cabazitaxel
(2)
+
-
abiraterone
(2)
+
-
docetaxel
(2)
+
-
prostate cancer
(2)
+
-
Author
Bergman, A.M.
(6)
+
-
Oort, I.M. van
(6)
+
-
Coenen, J.L.L.M.
(5)
+
-
Gelderblom, H.
(5)
+
-
Eertwegh, A.J.M. van den
(4)
+
-
Hamberg, P.
(4)
+
-
M. los
(4)
+
-
Wissing, M.D.
(3)
+
-
Badrising, S.K.
(2)
+
-
Berg, H.P. van den
(2)
+
-
Berg, P. van den
(2)
+
-
Haanen, J.B.
(2)
+
-
Jong, I.J. de
(2)
+
-
Kerver, E.D.
(2)
+
-
Noort, V. van der
(2)
+
-
Voorthuizen, T. van
(2)
+
-
Vrijaldenhoven, S.
(2)
+
-
Westgeest, H.M.
(2)
+
-
Wit, R. de
(2)
+
-
Show more
Language
en
(6)
+
-
Search results
(1 - 6 of 6)
show grid
show list
save search
Genetic aspects and molecular testing in prostate cancer
Enzalutamide as a Fourth- or Fifth-Line Treatment Option for Metastatic Castration-Resistant Prostate Cancer
Prognostic Parameters for Response to Enzalutamide After Docetaxel and Abiraterone Treatment in Metastatic Castration-Resistant Prostate Cancer Patients; a Possible Time Relation
CAST: A retrospective analysis of cabazitaxel and abiraterone acetate sequential treatment in patients with metastatic castrate-resistant prostate cancer previously treated with docetaxel
Cabazitaxel in Patients With Metastatic Castration-Resistant Prostate Cancer: Results of a Compassionate Use Program in The Netherlands
A retrospective study on cabazitaxel and abiraterone acetate sequential treatment (CAST) in docetaxel treated metastatic castrate-resistant prostate cancer patients